Top Biotech Stocks To Own For 2018

On Wednesday, our Elite Opportunity Pronewsletter suggested going long again on small cap gene therapy stock Spark Therapeutics (NASDAQ: ONCE):

Financially, Spark Therapeutics has over $300M in cash on the books and no debt to speak of yet, which equates to a share price of just over four times cash. The Company has generated over $20M in revenue for the trailing twelve months, and although the Company is expected to continue to lose money for the next few years, any strong clinical data that hits the tape could rocket shares of ONCE overnight, just like we’ve seen with so many others over the years.

It’s also interesting to note the stock still has insider ownership of over 40%, and that’s a huge number, especially for a small biotech like ONCE, but like with any small biotech, it doesn’t come without its risk. The Company is currently in phase I/II for its SPK-FIX, a program for the potential treatment of hemophilia B.

Top Biotech Stocks To Own For 2018: Cartesian, Inc.(CRTN)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggestedsmall cap professional services and technical solutions stock Cartesian Inc (NASDAQ: CRTN) as a long/bullish trade:

Top Biotech Stocks To Own For 2018: Texas Instruments Incorporated(TXN)

Advisors’ Opinion:

  • [By Keith Speights]

    That’s a pretty good definition of leadership, but it’s not an easy one to accomplish. However, the CEOs of Celgene (NASDAQ:CELG), Cognizant Technology Solutions (NASDAQ:CTSH), General Electric (NYSE:GE), MasterCard (NYSE:MA), and Texas Instruments (NASDAQ:TXN) have been able to achieve this translation very well.

  • [By Jim Cramer]

    Current return on equity exceeded its ROE from the same quarter one year prior. This is a clear sign of strength within the company. When compared to other companies in the Semiconductors & Semiconductor Equipment industry and the overall market, TEXAS INSTRUMENTS INC’s return on equity exceeds that of the industry average and significantly exceeds that of the S&P 500.

     

  • [By WWW.THESTREET.COM]

    Xilinx makes programmable logic chips that are used in a multitude of applications, from autos and defense to the data center. Cramer said with all of the takeover activity in the semiconductor space, he could see Xilinx becoming a target for the likes of Texas Instruments (TXN) or Micron Technologies (MU) , which may be looking to diversify away from cell phone chips.

  • [By Jim Cramer]

    The current debt-to-equity ratio, 0.41, is low and is below the industry average, implying that there has been successful management of debt levels. To add to this, TXN has a quick ratio of 1.69, which demonstrates the ability of the company to cover short-term liquidity needs.

     

Top Biotech Stocks To Own For 2018: U.S. Auto Parts Network, Inc.(PRTS)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, cyclical consumer goods & services shares rose by just 0.1 percent. Meanwhile, top losers in the sector included U.S. Auto Parts Network, Inc. (NASDAQ: PRTS), down 22 percent, and Sears Holdings Corp (NASDAQ: SHLD), down 13 percent.

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggestedshorting small cap online aftermarket auto parts stock U.S. Auto Parts Network, Inc (NASDAQ: PRTS):

Leave a Reply

Your email address will not be published. Required fields are marked *